DPP-4 Inhibitors in the Prevention/Treatment of Pulmonary Fibrosis, Heart and Kidney Injury Caused by COVID-19-A Therapeutic Approach of Choice in Type 2 Diabetic Patients?

• Autori principali: Andrija Smelcerovic (Autore), Gordana Kocic (Autore), Mihajlo Gajic (Autore), Katarina Tomovic (Autore), Vukica Djordjevic (Autore), Dobrila Stankovic-Djordjevic (Autore), Marko Anderluh (Autore)
• Natura: Libro
• Pubblicazione: Frontiers Media S.A., 2020-08-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Since the outbreak of SARS-CoV-2 virus more than 12,500,000 cases have been reported worldwide. Patients suffering from diabetes and other comorbidities are particularly susceptible to severe forms of the COVID-19, which might result in chronic complications following recovery. Dipeptidyl peptidase-...